Baird Financial Group, Inc. Ionis Pharmaceuticals Inc Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $294 - $374	7 Added 0.1%	6,696 $290,000
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $3,688 - $4,388	-85 Reduced 1.25%	6,689 $338,000
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $7,122 - $8,719	185 Added 2.81%	6,774 $307,000
Q2 2023 Aug 11, 2023	SELL	$34.73 - $43.33 $6,737 - $8,406	-194 Reduced 2.86%	6,589 $270,000
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $3,693 - $4,532	-110 Reduced 1.6%	6,783 $242,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $4,567 - $6,082	-125 Reduced 1.81%	6,772 $300,000
Q2 2022 Aug 08, 2022	SELL	$31.71 - $43.0 $107,687 - $146,028	-3,396 Reduced 32.99%	6,897 $255,000
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $31,762 - $39,373	-1,063 Reduced 9.36%	10,293 $381,000
Q4 2021 Feb 09, 2022	BUY	$25.61 - $35.1 $61,643 - $84,485	2,407 Added 26.9%	11,356 $346,000
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $52,087 - $62,974	1,553 Added 21.0%	8,949 $300,000
Q2 2021 Aug 11, 2021	BUY	$34.54 - $47.25 $12,745 - $17,435	369 Added 5.25%	7,396 $295,000
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $298,717 - $448,182	7,027 New	7,027 $316,000
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $198,103 - $262,816	-4,175 Closed	0 $0
Q2 2020 Oct 22, 2020	SELL	$46.85 - $61.05 $53,221 - $69,352	-1,136 Reduced 21.39%	4,175 $246,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $11,618 - $15,140	-248 Reduced 4.46%	5,311 $321,000
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $6,032 - $9,193	145 Added 2.68%	5,559 $263,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $22,993 - $27,870	-427 Reduced 7.31%	5,414 $327,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $1,004 - $1,226	17 Added 0.29%	5,841 $350,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $169,940 - $235,765	2,737 Added 88.66%	5,824 $375,000
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $163,364 - $250,571	3,087 New	3,087 $251,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account